Web-based Mobile Health Application for Patients With Liver Cirrhosis (ReLiver-N App)

This study evaluates the effect of a web-based mobile health application for patients with liver cirrhosis (ReLiver-N App) developed for enhancing patients' activation on the level of patient activation, self-efficacy, and quality of life. To manage liver cirrhosis after discharge, patients must continue to do some interventions at home like weight measurement, edema evaluation, and taking medications. To achieve this, the patient's activation level should be enhanced and that can contribute to hepatic rehabilitation. It would be beneficial to develop a web-based mobile health application for patients with liver cirrhosis that can enhance patient activation levels. The investigators developed the ReLiver-N App based ADDIE which is instructional design framework and created its contents of it. Our content includes patient education information about liver cirrhosis, patient activity tasks and measurements questionnaires. Ten experts evaluated the quality of the content and the investigators conducted a feasibility test with three patients to assess the usability of the ReLiver-N App. A single-blind randomized controlled trial design will be applied. Patients with liver cirrhosis will be pretested and randomized (intervention: 26, control: 26) to the ReLiver-N App group and control group. The investigators will clustered the participants through Child-Pugh scores. Both the ReLiver-N App group and control group will use the ReLiver-N App for three months. While participants in the ReLiver-N group can reach all content of the ReLiver-N App, others can reach only these fields "patient activity tasks." and "measurements questionnaires". The effectiveness of the ReLiver-N App is planned to be evaluated at the beginning, 1, 2, and 3 months.

Inclusion Criteria:Diagnosed with liver cirrhosisHad Child-Pugh A and B categories18 years of age or olderNo barriers to verbal or written communicationHaving internet at home and a smartphone Patients who consented to participate in the study.Exclusion Criteria:Had Child-Pugh C categoryHad pregnantLiver transplantedDiagnosed with hepatocellular carcinomaHaving dementiaHaving been diagnosed with a psychiatric disease